The future of personalized nanomedicine in cancer treatment appears promising. Advances in genomics and biotechnology are expected to enhance the precision of nanoparticle design, enabling even more tailored therapies. Additionally, the integration of artificial intelligence and machine learning could facilitate the development of predictive models, optimizing treatment plans for individual patients.
Furthermore, ongoing research into multifunctional nanoparticles that can diagnose, deliver drugs, and monitor therapeutic response in real-time holds significant potential. As technology progresses, personalized nanomedicine could become a cornerstone of cancer treatment, offering hope for more effective and less toxic therapies.
